SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
141 hedge funds and large institutions have $297M invested in SANGAMO THERAPEUTICS INC in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 34 reducing their positions, and 35 closing their positions.
632% more call options, than puts
Call options by funds: $17.6M | Put options by funds: $2.41M
68% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 34
10% less funds holding
Funds holding: 156 → 141 (-15)
43% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 35
47% less capital invested
Capital invested by funds: $560M → $297M (-$263M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$30.8M |
| 2 |
Millennium Management
New York
|
+$13.1M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$8.66M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.83M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$19.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$15M |
| 3 |
PA
Perceptive Advisors
New York
|
-$8.87M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.94M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$6.75M |
SGMO Hedge Fund Activity: Q3 2015 in Review
141 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2015, worth a combined $297M — down 47% from $560M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of SGMO and 20 opened new positions — a net loss of 15 holders — while 34 trimmed existing stakes and 57 added.
The largest buyer was Wasatch Advisors, adding an estimated $30.8M. The largest seller was Jennison Associates, exiting entirely with an estimated $19.2M sold.
- 141 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2015, down from 156 in Q2 2015.
- Funds reported $297M of SANGAMO THERAPEUTICS INC stock for Q3 2015, down 47% quarter-over-quarter.
- 20 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2015 and 35 closed out, a net change of -15 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q3 2015 was Wasatch Advisors, an estimated $30.8M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q3 2015 was Jennison Associates, an estimated $19.2M sold.
Based on aggregated 13F filings for Q3 2015.